NCT00059696

Brief Summary

After a stroke, many patients are left with an impaired arm. Restricting the use of the good arm may improve the use of the bad arm. In "Constraint-Induced Movement" therapy (CI therapy), the good arm is put in a sling to force increased use of the bad arm. The bad arm is also trained each day for several weeks. This study will evaluate the effectiveness of CI therapy in patients with chronic disability after stroke and whether the rate of recovery is decreased in elderly patients.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 1999

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

May 1, 2003

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 5, 2003

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2004

Completed
Last Updated

September 26, 2016

Status Verified

May 1, 2011

Enrollment Period

4.9 years

First QC Date

May 1, 2003

Last Update Submit

September 23, 2016

Conditions

Keywords

Constraint-Induced Movement TherapyCI therapyRehabilitationCerebrovascular accidentUpper extremityConcentrated, extended practiceLimb restraintMotor Deficits

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First stroke \> 12 months prior to study entry
  • Impaired Flexor synergy, pronation and supination of forearm, active wrist extension, active finger extension, and active grasp and release
  • Minimum passive range of motion and spasticity criteria (defined as stroke patients who fall into approximately the second to lowest quartile of motor functioning as determined by the Fugl-Meyer Test)
  • Available for follow-up at the treatment site (3 years for control patients; 2 years for intervention patients)

You may not qualify if:

  • Folstein Mini-Mental State Examination score \< 24
  • Token Test of the Multilingual Aphasia Examination score \< 36
  • Excessive frailty or lack of stamina (e.g., cannot attend to instructions, stay awake, engage in functional activities) as determined by study officials
  • Serious uncontrolled medical conditions
  • Excessive pain in any joint of the affected extremity that could limit ability to cooperate with the intervention, as judged by study officials
  • Unable to stand independently for 2 minutes, transfer independently to and from the toilet, or perform sit-to-stand
  • Current participation in other pharmacological or physical intervention studies
  • Injections of anti-spasticity drugs into upper extremity musculature within the past 3 months or wish to have drugs injected in the foreseeable future
  • Any oral anti-spasticity drugs at study entry
  • Phenol injections within 12 months prior to study entry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35294-1170, United States

Location

Related Publications (9)

  • Taub, E. (1994). Overcoming learned nonuse: A new behavioral medicine approach to physical medicine. In J. G. Carlson, S. R. Seifert, & N. Birbaumer. (eds.) Clinical applied psychophysiology (pp. 185-220). New York: Plenum.

    BACKGROUND
  • Taub E, Crago JE, Burgio LD, Groomes TE, Cook EW 3rd, DeLuca SC, Miller NE. An operant approach to rehabilitation medicine: overcoming learned nonuse by shaping. J Exp Anal Behav. 1994 Mar;61(2):281-93. doi: 10.1901/jeab.1994.61-281.

    PMID: 8169577BACKGROUND
  • Taub E, Wolf SL. Constraint Induced Movement Techniques To Facilitate Upper Extremity Use in Stroke Patients. Top Stroke Rehabil. 1997 Jan;3(4):38-61. doi: 10.1080/10749357.1997.11754128.

    PMID: 27620374BACKGROUND
  • Taub E, Crago JE, Uswatte, G: Constraint-Induced Movement Therapy: A new approach to treatment in physical rehabilitation. Rehabilitation Psychology 43: 152-170, 1998.

    BACKGROUND
  • Miltner WH, Bauder H, Sommer M, Dettmers C, Taub E. Effects of constraint-induced movement therapy on patients with chronic motor deficits after stroke: a replication. Stroke. 1999 Mar;30(3):586-92. doi: 10.1161/01.str.30.3.586.

    PMID: 10066856BACKGROUND
  • Taub E, Uswatte G, Pidikiti R. Constraint-Induced Movement Therapy: a new family of techniques with broad application to physical rehabilitation--a clinical review. J Rehabil Res Dev. 1999 Jul;36(3):237-51.

    PMID: 10659807BACKGROUND
  • Kunkel A, Kopp B, Muller G, Villringer K, Villringer A, Taub E, Flor H. Constraint-induced movement therapy for motor recovery in chronic stroke patients. Arch Phys Med Rehabil. 1999 Jun;80(6):624-8. doi: 10.1016/s0003-9993(99)90163-6.

    PMID: 10378486BACKGROUND
  • Taub E, Miller NE, Novack TA, Cook EW 3rd, Fleming WC, Nepomuceno CS, Connell JS, Crago JE. Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil. 1993 Apr;74(4):347-54.

    PMID: 8466415BACKGROUND
  • Taub E, Uswatte G, Elbert T. New treatments in neurorehabilitation founded on basic research. Nat Rev Neurosci. 2002 Mar;3(3):228-36. doi: 10.1038/nrn754.

    PMID: 11994754BACKGROUND

MeSH Terms

Conditions

Cerebrovascular DisordersStrokeNeurologic Manifestations

Interventions

Constraint Induced Movement Therapy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyPhysical Therapy ModalitiesTherapeuticsRehabilitation

Study Officials

  • Edward Taub, Ph.D.

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
NIH

Study Record Dates

First Submitted

May 1, 2003

First Posted

May 5, 2003

Study Start

December 1, 1999

Primary Completion

November 1, 2004

Last Updated

September 26, 2016

Record last verified: 2011-05

Locations